MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
10.24
-0.21 (-2.01%)
Sep 29, 2026, 12:58 PM EDT - Market open
MapLight Therapeutics Employees
MapLight Therapeutics had 133 employees as of December 31, 2025. The number of employees increased by 70 or 111.11% compared to the previous year.
Employees
133
Change
70
Growth
111.11%
Revenue / Employee
n/a
Profits / Employee
-$1,728,023
Market Cap
569.10M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 133 | 30 | 29.13% |
| Sep 30, 2025 | 114 | - | - |
| Jun 30, 2025 | 109 | 35 | 47.30% |
| Mar 31, 2025 | 103 | 29 | 39.19% |
| Mar 31, 2024 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| Phathom Pharmaceuticals | 371 |
| Allogene Therapeutics | 152 |
| Neurogene | 131 |
| CytomX Therapeutics | 69 |
| Crescent Biopharma | 69 |
| Oculis Holding AG | 60 |
| Altimmune | 57 |
MPLT News
- 11 days ago - MapLight Therapeutics Registration statement: Registration filing - Filings
- 19 days ago - MapLight Therapeutics files to sell 13.18M shares of common stock for holders - TheFly
- 20 days ago - MapLight Therapeutics Registration statement: Registration filing - Filings
- 20 days ago - MapLight Therapeutics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 4 weeks ago - MapLight Therapeutics price target lowered to $43 from $45 at Needham - TheFly
- 6 weeks ago - MapLight Therapeutics announces $150M private placement - TheFly
- 6 weeks ago - MapLight Therapeutics reports Q2 EPS ($1.32), consensus ($1.31) - TheFly
- 6 weeks ago - MapLight Therapeutics price target lowered to $31 from $35 at Raymond James - TheFly